The therapeutic era of peptides began in 1921 with the discovery of insulin, a breakthrough that revolutionized diabetes and helped establish biologic therapies in medicine Since then, peptide hormones like oxytocin and human growth hormone (GH) have entered clinical use, and glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide are now widely prescribed for obesity and metabolic diseaseconditions increasingly recognized for their effect on orthopaedic outcomes
Indeed, Versanis Bio have tried a combination of bimagrumab and semaglutide in a prior phase 2a study assessing bimagrumab in patients with obesity and type 2 diabetes
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial
It gets deep inside the skin and provides nourishment to the skin
Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, et al